Danaher topped first-quarter profit expectations, helped by strong demand for its bioprocessing tools used in drug manufacturing. The earnings beat lifted shares 2% in premarket trading, signaling a modestly positive reaction. The report points to solid underlying demand in its life sciences and bioprocessing businesses.
Danaher topped first-quarter profit expectations, helped by strong demand for its bioprocessing tools used in drug manufacturing. The earnings beat lifted shares 2% in premarket trading, signaling a modestly positive reaction. The report points to solid underlying demand in its life sciences and bioprocessing businesses.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.55
Ticker Sentiment
